Sci & Tech● Low30m ago · Nov 12, 2026, 1:24 AM
Miro clears TGA audit ahead of Crohn’s disease trial
GlobeAlert Desk · curated from Sydney Morning Herald · Australia · Oceania
Miro Sciences has cleared a TGA manufacturing hurdle for its Crohn’s trial, with the regulator inspecting its partner’s facility ahead of a planned Phase 2 study for its StemSmart cell therapy.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text. How we score stories.
GlobeAlert context
What the desk knows about this story
Threat level
1 Low
Scored from severity, scale, escalation potential and source agreement. Below the alert threshold.
Sources
1 publisher
Single-source so far. Treat details as unconfirmed until more publishers report.
Category
Sci & Tech
Not flagged as developing.
More from Australia
Sci & Tech1h agoCan Southeast Asia cut and paste Australia’s AI safeguards?South China Morning PostPolitics2h agoShould Australia spend $32,000 on coffees for COP? Why Turnbull says yesSydney Morning Herald · AustraliaMilitary8h agoAustralian Army’s littoral transformation is the right move, experts sayBreaking DefenseBusiness19h agoShock reshuffle at Australian Women’s Weekly as top editor departsSydney Morning Herald · Australia
More in Sci & Tech
Sci & Tech23m agoFrancis Ford Coppola defends human judgment in cinema against AI in MexicoInfobae · ArgentinaSci & Tech54m agoChina has more than 20 small nuclear reactor start-ups. Should the US worry?South China Morning PostSci & Tech1h agoAs U.S. pushes back on data centers, China races to build them and catch upNBC NewsSci & Tech1h agoMeta's Muse arrives on smartwatches and allows task management through connected servicesInfobae · Argentina